Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jason Gerberry is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/16/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/16/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $49.84 | 34.43% | $64 → $67 | Maintains | Buy | Get Alert |
| 06/11/2024 | OCS | Buy Now | Oculis Holding | $12.58 | 59% | $21 → $20 | Maintains | Buy | Get Alert |
| 05/30/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.67 | 25.97% | $18 → $21 | Maintains | Buy | Get Alert |
| 05/29/2024 | PROK | Buy Now | ProKidney | $2.41 | 65.98% | $3 → $4 | Maintains | Neutral | Get Alert |
| 04/17/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $78.57 | 15.82% | $82 → $91 | Maintains | Buy | Get Alert |
| 04/01/2024 | GLPG | Buy Now | Galapagos | $26.37 | 17.56% | $41 → $31 | Downgrade | Neutral → Underperform | Get Alert |
| 03/28/2024 | GLPG | Buy Now | Galapagos | $26.37 | 17.56% | $41 → $31 | Downgrade | Neutral → Underperform | Get Alert |
| 03/25/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.30 | 3518.42% | $12 → $11 | Maintains | Buy | Get Alert |
| 03/07/2024 | CPRX | Buy Now | Catalyst Pharmaceuticals | $16.99 | 35.37% | → $23 | Initiates | → Buy | Get Alert |
| 01/02/2024 | ALKS | Buy Now | Alkermes | $24.60 | 17.89% | $27 → $29 | Maintains | Neutral | Get Alert |
| 01/02/2024 | ARWR | Buy Now | Arrowhead Pharma | $29.54 | 25.25% | $29 → $37 | Maintains | Buy | Get Alert |
| 01/02/2024 | GLPG | Buy Now | Galapagos | $26.37 | 66.86% | $41 → $44 | Maintains | Neutral | Get Alert |
| 01/02/2024 | PCVX | Buy Now | Vaxcyte | $83.24 | -3.89% | $67 → $80 | Maintains | Buy | Get Alert |
| 01/02/2024 | XENE | Buy Now | Xenon Pharmaceuticals | $42.94 | 30.41% | $52 → $56 | Maintains | Buy | Get Alert |
| 01/02/2024 | PROK | Buy Now | ProKidney | $2.41 | -17.01% | $8 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 01/02/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $49.84 | 24.4% | $52 → $62 | Upgrade | Neutral → Buy | Get Alert |
| 01/02/2024 | HRMY | Buy Now | Harmony Biosciences | $34.71 | -13.57% | → $30 | Downgrade | Neutral → Underperform | Get Alert |
| 12/21/2023 | BLUE | Buy Now | bluebird bio | $1.35 | 270.37% | $12 → $5 | Maintains | Buy | Get Alert |
| 12/21/2023 | IMVT | Buy Now | Immunovant | $31.04 | 64.3% | $49 → $51 | Maintains | Buy | Get Alert |
| 12/11/2023 | BLUE | Buy Now | bluebird bio | $1.35 | 788.89% | $11 → $12 | Maintains | Buy | Get Alert |
| 12/04/2023 | ARWR | Buy Now | Arrowhead Pharma | $29.54 | -1.83% | → $29 | Initiates | → Buy | Get Alert |
| 11/17/2023 | AMPH | Buy Now | Amphastar Pharma | $39.64 | 58.93% | → $63 | Initiates | → Neutral | Get Alert |
| 10/23/2023 | VTRS | Buy Now | Viatris | $11.38 | -20.91% | → $9 | Downgrade | Neutral → Underperform | Get Alert |
| 10/23/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $49.84 | 4.33% | $33 → $52 | Upgrade | Underperform → Neutral | Get Alert |
| 09/12/2023 | LYRA | Buy Now | Lyra Therapeutics | $0.30 | 4834.21% | $13 → $15 | Maintains | Buy | Get Alert |
| 09/08/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.67 | -22.02% | $12 → $13 | Maintains | Buy | Get Alert |
| 09/08/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | $304 → $259 | Maintains | Buy | Get Alert |
| 08/30/2023 | OCS | Buy Now | Oculis Holding | $12.58 | 90.8% | $23 → $24 | Maintains | Buy | Get Alert |
| 08/10/2023 | JAZZ | Buy Now | Jazz Pharmaceuticals | $106.09 | 104.54% | $204 → $217 | Maintains | Buy | Get Alert |
| 08/08/2023 | FGEN | Buy Now | FibroGen | $1.07 | 86.92% | $4 → $2 | Downgrade | Neutral → Underperform | Get Alert |
| 08/08/2023 | AXSM | Buy Now | Axsome Therapeutics | $84.95 | -4.65% | $59 → $81 | Upgrade | Underperform → Neutral | Get Alert |
| 07/19/2023 | BLUE | Buy Now | bluebird bio | $1.35 | 640.74% | $6 → $10 | Upgrade | Neutral → Buy | Get Alert |
| 06/26/2023 | FGEN | Buy Now | FibroGen | $1.07 | 273.83% | $29 → $4 | Downgrade | Buy → Neutral | Get Alert |
| 06/14/2023 | OCS | Buy Now | Oculis Holding | $12.58 | 74.9% | → $22 | Initiates | → Buy | Get Alert |
| 05/24/2023 | LLY | Buy Now | Eli Lilly | $941.50 | -46.89% | $450 → $500 | Maintains | Buy | Get Alert |
| 05/23/2023 | IMVT | Buy Now | Immunovant | $31.04 | -9.79% | $26 → $28 | Maintains | Buy | Get Alert |
| 05/16/2023 | CARA | Buy Now | Cara Therapeutics | $0.37 | 981.08% | $6 → $4 | Maintains | Underperform | Get Alert |
| 05/11/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.67 | -34.01% | $13 → $11 | Maintains | Buy | Get Alert |
| 05/10/2023 | ACLX | Buy Now | Arcellx | $65.92 | -24.15% | $39 → $50 | Maintains | Buy | Get Alert |
| 05/01/2023 | IMVT | Buy Now | Immunovant | $31.04 | -16.24% | → $26 | Initiates | → Buy | Get Alert |
| 04/20/2023 | HRMY | Buy Now | Harmony Biosciences | $34.71 | 0.84% | → $35 | Initiates | → Neutral | Get Alert |
| 04/18/2023 | PCVX | Buy Now | Vaxcyte | $83.24 | -18.31% | $63 → $68 | Maintains | Buy | Get Alert |
| 03/30/2023 | BLUE | Buy Now | bluebird bio | $1.35 | 344.44% | $8 → $6 | Maintains | Neutral | Get Alert |
| 03/08/2023 | CARA | Buy Now | Cara Therapeutics | $0.37 | 1521.62% | $13 → $6 | Downgrade | Neutral → Underperform | Get Alert |
| 02/14/2023 | AXSM | Buy Now | Axsome Therapeutics | $84.95 | -38.79% | → $52 | Reiterates | → Underperform | Get Alert |
| 01/05/2023 | AMTI | Buy Now | Applied Molecular | — | — | $5 → $0.5 | Downgrade | Buy → Underperform | Get Alert |
| 01/05/2023 | FGEN | Buy Now | FibroGen | $1.07 | 2423.36% | $18 → $27 | Upgrade | Neutral → Buy | Get Alert |
| 12/13/2022 | ACLX | Buy Now | Arcellx | $65.92 | -43.87% | → $37 | Reinstates | → Buy | Get Alert |
| 12/12/2022 | ALLO | Buy Now | Allogene Therapeutics | $3.40 | 164.71% | → $9 | Downgrade | Buy → Underperform | Get Alert |
| 10/14/2022 | ALKS | Buy Now | Alkermes | $24.60 | 1.63% | $27 → $25 | Upgrade | Underperform → Neutral | Get Alert |
| 10/14/2022 | OGN | Buy Now | Organon | $20.81 | 20.13% | $37 → $25 | Downgrade | Neutral → Underperform | Get Alert |
| 08/29/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $42.94 | — | — | Initiates | → Buy | Get Alert |
| 08/09/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | $160 → $261 | Maintains | Buy | Get Alert |
| 08/05/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.67 | -22.02% | $10 → $13 | Upgrade | Neutral → Buy | Get Alert |
| 08/05/2022 | OGN | Buy Now | Organon | $20.81 | 77.8% | $40 → $37 | Downgrade | Buy → Neutral | Get Alert |
| 05/17/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.67 | -46.01% | → $9 | Upgrade | Underperform → Neutral | Get Alert |
| 03/01/2022 | VTRS | Buy Now | Viatris | $11.38 | 14.24% | $21 → $13 | Downgrade | Buy → Neutral | Get Alert |
| 03/01/2022 | ACLX | Buy Now | Arcellx | $65.92 | -63.59% | → $24 | Initiates | → Buy | Get Alert |
| 02/01/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $171 → $141 | Upgrade | Underperform → Neutral | Get Alert |
| 02/01/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $49.84 | -39.81% | $40 → $30 | Downgrade | Buy → Underperform | Get Alert |
| 12/02/2021 | BYSI | Buy Now | BeyondSpring | $2.42 | 106.61% | — | Downgrade | Buy → Underperform | Get Alert |
| 06/19/2020 | LLY | Buy Now | Eli Lilly | $941.50 | -80.88% | $165 → $180 | Maintains | Buy | Get Alert |
